Oruka Therapeutics (ORKA) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 118.16% |
| Dec 31, 2025 | 196.36% |
| Sep 30, 2025 | 358.80% |
| Jun 30, 2025 | 317.55% |
| Mar 31, 2025 | 213.99% |
| Dec 31, 2024 | 185.82% |
| Sep 30, 2024 | 215.05% |
| Jun 30, 2024 | 72.28% |
| Mar 31, 2024 | 14.87% |
| Dec 31, 2023 | 19.44% |
| Sep 30, 2023 | 21.57% |
| Jun 30, 2023 | 25.53% |
| Mar 31, 2023 | 16.03% |
| Dec 31, 2022 | 0.17% |
| Sep 30, 2022 | -4.01% |
| Jun 30, 2022 | 7.65% |
| Mar 31, 2022 | 10.58% |
| Dec 31, 2021 | 43.59% |
| Sep 30, 2021 | -17.19% |
| Jun 30, 2021 | -6.18% |
| Mar 31, 2021 | -1.88% |
| Dec 31, 2020 | -34.12% |
| Sep 30, 2020 | -49.28% |
| Jun 30, 2020 | -53.03% |
| Mar 31, 2020 | -34.23% |
| Dec 31, 2019 | -29.59% |
| Sep 30, 2019 | -29.02% |
| Jun 30, 2019 | -23.52% |
| Mar 31, 2019 | -20.56% |
| Dec 31, 2018 | -18.16% |
| Sep 30, 2018 | 3.43% |
| Jun 30, 2018 | 12.03% |
| Mar 31, 2018 | 18.22% |
| Dec 31, 2017 | 13.56% |
| Sep 30, 2017 | 9.97% |
| Jun 30, 2017 | 8.82% |
| Mar 31, 2017 | 2.11% |
| Dec 31, 2016 | -18.95% |
| Sep 30, 2016 | 27.58% |
| Jun 30, 2016 | 19.53% |
| Mar 31, 2016 | 14.72% |
| Dec 31, 2015 | 3.69% |
| Sep 30, 2015 | 5.69% |